 
      Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid
MELBOURNE, Australia, April 26, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited TLX Telix, the Company) today announces the expansion of its artificial intelligence (AI) capability with the signing of an agreement to acquire Vienna-based Dedicaid GmbH ( …
 
       
  
 
     
     
     
     
     
     
     
     
     
     
     
    